Alvotech partnership to co-develop biosimilar candidate to Keytruda® Hyderabad-headquartered Dr. Reddy’s Laboratories Ltd (BSE: 500124 | NSE: DRREDDY | NYSE: RDY | NSEIFSC: DRREDDY) remains bullish on global business prospects as it reported 11% Y-on-Y increase in revenue to Rs.85.452...
Read moreDetails









